Retinal neovascularization is a condition in which abnormal blood vessels grow on the surface of the retina. It is a major cause of vision loss in adults and can lead to blindness if left untreated. Optical treatments for retinal neovascularization include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation uses a laser to seal off the abnormal blood vessels, while photodynamic therapy uses a light-activated drug to destroy the abnormal vessels. Anti-VEGF injections are used to block the growth of new vessels.
The retinal neovascularization market is a rapidly growing segment of the optical industry. It is driven by the increasing prevalence of age-related macular degeneration, diabetic retinopathy, and other retinal diseases. Companies in the market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, and Topcon. Show Less Read more
